indazoles has been researched along with dinitrofluorobenzene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, Y; Li, H; Li, LM; Li, MH; Liu, J; Liu, Y; Luo, XY; Wang, YT; Yang, P; Yang, SX; Yang, T; Zheng, J; Zou, Q | 1 |
| Chen, ZL; Lai, Y; Li, H; Li, LM; Li, MH; Liu, J; Liu, Y; Luo, XY; Wang, YT; Yang, SX; Yang, T; Zou, Q | 1 |
2 other study(ies) available for indazoles and dinitrofluorobenzene
| Article | Year |
|---|---|
BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway.
Topics: Allergens; Animals; Benzothiazoles; Cell Cycle; Cell Proliferation; Dinitrofluorobenzene; Female; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Indazoles; Interleukin-2; Janus Kinase 3; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes | 2013 |
A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation.
Topics: Animals; Benzimidazoles; Benzothiazoles; Cell Proliferation; Cells, Cultured; Cyclin D3; Cyclin-Dependent Kinase 6; Cytokines; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Humans; Immunosuppressive Agents; Indazoles; Lymphocyte Activation; Mice, Inbred BALB C; Phosphorylation; Signal Transduction; Solubility; STAT5 Transcription Factor; T-Lymphocytes; Water | 2015 |